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Abstract: Aflatoxins are produced by the fungi Aspergillus flavus and Aspergillus parasiticus and are
common food contaminants in tropical developing countries. Extensive aflatoxin consumption has
been shown to be highly associated with liver disease. A case-control study was conducted to
determine the association between aflatoxin and liver disease in Kumasi, Ghana. A questionnaire
was administered to examine socio-demographic characteristics and food storage and consumption
practices, and urine samples were collected to measure levels of the aflatoxin metabolite (AFM1).
Two hundred and seventy-six people participated in the study; 38 had liver disease (cases), 136
had neither hepatitis B/C nor liver disease (negative controls), and 102 were hepatitis B/C positive
without liver cancer (positive controls). A much higher percent of participants in each group was
male (76% of cases, 88% of negative controls and 65% of positive controls). Multivariate analysis
showed that age was a significant predictor for being a case when cases were compared to negative
controls. The odds of being a case was 70% less for participants aged 25–34 years (odds ratios (OR)
0.30; 95% confidence interval (CI) 0.10–0.88) compared to those ě45 years. For cases; Akans were
seven times more likely to have AFM1 levels below the median when compared to other ethnic
groups (OR 7; CI 1.41–34.68). When cases were compared to positive controls, they were 2.29 times
more likely to report awareness of aflatoxin contamination of groundnuts (95% CI 1.06–4.91). Cases
were also two times more likely to report awareness of aflatoxin contamination of maize than all
controls combined (95% CI 1.02–4.11). However, most cases reported that aflatoxin contamination
does not cause sickness in humans. This shows that there is awareness of aflatoxin contamination
without proper understanding of the serious potential adverse health impacts among these study
participants. These findings indicate that educational interventions that stress the harmful health
effects of aflatoxin in food, with an emphasis on the higher risk for males, are urgently needed.
The reasons for lower aflatoxin levels among Akans need to be determined, and the findings used to
design interventions that benefit other ethnic groups in the society.
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1. Introduction
Aflatoxins are a group of extremely toxic metabolites produced by the common fungi
Aspergillus flavus and A. parasiticus. Although the major aflatoxins (B1, B2, G1 and G2) occur together
in various foods in different proportions, aflatoxin B1 (AFB1) is usually the predominant and most
toxic form [1,2]. AFM1 is a major metabolite of AFB1 and is frequently excreted in milk and urine
of humans, dairy cattle and other mammals that have consumed food or feed contaminated with
aflatoxins [1]. The aflatoxin B1-8,9-epoxide, which is formed from aflatoxin B1 (AFB1) by cytochrome
p450 oxidation, is highly reactive and can bind to DNA, RNA and proteins forming adducts and
resulting in cancer and toxicity [3,4]. The conditions that favour growth of the fungi that produce
aflatoxin are optimal in Ghana. Moreover, staple foods such as, maize, groundnuts and other grains
are often contaminated with levels of aflatoxin that far exceed the 30 µg/Kg considered tolerable in
food for human consumption by the FAO/WHO/UNICEF Protein Advisory Board [5]. The most
severe effect of aflatoxin in the human body is seen in the liver, which is generally responsible for
detoxifying chemical agents and poisons.
The adverse health effects of aflatoxins can be categorized as either acute or chronic. In acute
aflatoxicosis, binding of the AFB1-epoxide to various cellular macromolecules leads to hepatocellular
injury and death [6]. Acute aflatoxicosis manifests as severe, acute hepatotoxicity with a case-fatality
rate of up to 39% [7,8]. Symptoms include acute liver damage, rapid progressive jaundice, edema of
the limbs, high fever, abdominal pain, vomiting, fulminant hepatic failure and possibly death.
Chronic exposure to aflatoxin causes carcinoma of the liver [9], and both epidemiological and
animal studies show that hepatitis B virus (HBV) and aflatoxin work synergistically to increase the risk
of hepatocellular carcinoma (HCC) [10,11]. HCC is the fifth most frequently occurring cancer in the
world [12], with an estimated 0.5–1 million cases annually, most of which occur in sub-Saharan Africa
and Southeast Asia including China [13–15].
Pre-existing liver disease due to HBV or hepatitis C virus (HCV) infections may compromise the
ability of hepatocytes to inactivate carcinogens such as aflatoxin [16]. We found a high prevalence
of hepatitis infection in a study population in the Ejura Sekyedumase district, an Ashanti region of
Ghana [17]. Forty-three of 140 participants (30.7%) tested positive for HBV or HCV infections; 23
(16.4%) for HBV and 20 (14.3%) for HCV; three participants were positive for both HBV and HCV
infections. In another study that we conducted among HIV positive people in Kumasi, 11% were HBV
positive and 1.3% HCV positive [18]. HBV infection was marginally associated with high aflatoxin
biomarker levels and HBV positive participants had 2.38 times greater risk of having high aflatoxin B1
biomarker levels than HBV negative. The World Health Organization estimated that approximately
12% of the Ghanaian population has been infected with HBV and 2.8% with HCV [19]. In Kumasi the
prevalence of HBV and HCV was previously reported to be 15% and 2.3% respectively [20].
This study was designed to determine aflatoxin biomarker levels in HBV and HCV positive
patients compared with HBV and HCV negative controls and examine the association between
aflatoxin biomarker levels and liver disease or liver cancer. A secondary objective was to examine
predictors of high aflatoxin biomarker levels in study participants. As with most chronic diseases
in Africa, patients with liver disease/cancer seek medical attention only when it is too late for any
meaningful intervention to be implemented. Therefore, this study was conducted to provide data that
can be used to formulate educational and other interventions to decrease aflatoxin intake, improve
the quality of life, and reduce the high mortality associated with liver cancer in Ghana. In Ghana, the
commonest cause of cancer death in females was malignancies of the breast (Age-Standardized Cancer
Ratio, 17.24%), followed closely by hematopoietic organs (14.69%), liver (10.97%) and cervix (8.47%);
whilst in males, the highest cancer mortality was from liver (21.15%), followed by prostate (17.35%),
hematopoietic organs (15.57%), and stomach (7.26%) [21].
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2. Experimental Section
2.1. Methods
A case-control study was conducted among patients attending clinics at the Komfo Anoyke
Teaching Hospital (KATH) in Kumasi, the capital city of the Ashanti region of Ghana, from June 2012
to August 2013. KATH is a 1200-bed facility in the city of Kumasi and the second-largest hospital in
Ghana [22]. It is the teaching hospital of the Kwame Nkrumah University of Science and Technology
(KNUST) Medical School. KATH is the only tertiary health institution in the Ashanti Region and serves
a population of 10 million people who primarily reside in Ashanti, Brong Ahafo, Northern, Upper East
and Upper West Regions of Ghana [23]. Cases were defined as HBV/HCV positive patients who were
clinically diagnosed with liver disease (e.g., alanine aminotransferase (ALT) level ě60) or liver cancer
that were biochemically confirmed through liver function tests and imaging with liver ultrasound and
liver fibroscan. Two groups of controls were recruited for the study from the Transfusion Medicine
Unit at KATH. Positive control participants were identified as patients diagnosed with HBV/HCV
without any evident symptoms of acute liver damage and ALT test scores within the normal range.
Negative controls were people who came in for routine blood donations, who tested negative for HBV
and HCV, and who self-reported no liver problems. The response rate in the study was 80%.
Participants were Ghanaian men and women who were 18 years of age and older, and who
belonged to the different ethnic groups representative of the Ashanti region, such as, the Akans,
Gruma, Busanga, Dagbani, Basare, Moshi, Hausa, Ewe and Dagati. After informed consent was
obtained, participants were asked to complete an interviewer-administered questionnaire that included
questions on: (1) socio-demographic factors (age, sex, marital status, income, education, religion, and
occupation); and (2) eating habits (basic staple foods, food acquisition, storage and preparation).
A private room was used for interviewing to ensure confidentiality. A sample of freshly voided
urine was collected to screen for the aflatoxin M1 metabolite. The participants’ medical records were
reviewed and clinical data, such as liver function tests, liver ultrasounds, fibroscans, and stage of liver
cancer, were abstracted.
2.2. Determination of Aflatoxin M1 Levels in Urine
Urine samples were centrifuged at 2300 rpm, and 5.0 mL of supernatant was collected, acidified
with 0.5 mL of 1.0 M ammonium formate (pH 4.5) and diluted with water to a total volume of 10.0 mL.
Samples were then loaded onto a 3 mL preparative Aflatest WB immunoaffinity column (VICAM,
Watertown, MA, USA) at a flow rate of 1 mL/min. Following washing of the column the aflatoxin
fraction was eluted from the column with 2 mL of 80% methanol, dried under N2 and re-suspended
in 200 mL of a 1:1 solution of methanol:20 mM ammonium formate. Samples were analyzed using a
Shimadzu HPLC system (Shimadzu Corporation, Kyoto, Japan) with fluorescence detection capabilities.
A 250 4.6 mm LiCrospher RP-18 column with pore size 100 Å and particle size 5 mm (Alltech Associates,
Deerfield, IL, USA) was used to resolve aflatoxin metabolites. The mobile phase consisted of 22%
ethanol buffered with 20 mM ammonium formate (pH 3.0) in water. Isocratic elution of the mobile
phase for 20 min at a rate of 1 mL/min allowed for proper chromatographic separation. External AFM1
standards were prepared weekly and injected following every five injections of samples. The limit
of detection for this method was 0.5 pg/mg of urine for AFM1. Urinary AFM1 concentrations were
expressed as pg/mL creatinine to correct for variations in urine dilution among samples. Creatinine
concentrations were measured by a Selectra E auto-analyzer (Vital Scientific, Dieren, The Netherlands).
2.3. Statistical Analysis
Analysis was performed on 276 participants (38 cases, 136 negative controls and 102 positive
controls). Bivariate analyses (chi-square and Fisher’s exact tests for categorical variables and t-test
and analysis of variance for continuous variables) were used to compare differences between the
three groups. Factors that had p ď 0.1 were carried forward to the multivariate model. This more
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conservative p ď 0.1 was selected in order to protect against residual confounding. Because there
were three groups for the logistic model various comparisons were performed. In the first model
cases were compared to both positive and negative controls, the second model included cases versus
positive controls only, and the third was a comparison of cases and negative controls only. Logistic
regression was used for all models to estimate odds ratios (ORs) and 95% confidence intervals (CIs)
for the association between sociodemographic variables, aflatoxin awareness and food consumption
practices, and being a case when compared to other groups. SAS 9.4 (SAS institute, Cary, NC, USA)
was used for analyses. For all statistical tests a two-sided p-value < 0.05 was considered significant.
3. Results
3.1. Sociodemographic and Clinical Characteristics of the Study Groups
Participants differed according to sex and age (Table 1). A much higher percentage of participants
in all groups were male. Cases were significantly older when compared to negative and positive
controls (p = 0.0370). Most participants were Akans, Christians, employed, and had junior secondary
school (JSS)/secondary education. Mean AFM1 levels (pg/mg creatinine) for cases (68.52 ˘ 679.8),
positive controls (65.28 ˘ 334.1) and negative controls (67.02 ˘ 160.1) did not differ significantly from
each other (Table 2). Although the median AFM1 levels was higher for cases (9.94 pg/mg) than for
negative (7.72 pg/mg) and positive (6.76 pg/mg) controls the difference was also not significant.
However, levels of the liver enzymes, aspartate transaminase (AST) and alanine transaminase (ALT)
were significantly different between cases and positive controls. Mean levels of AST and ALT for
positive controls remained within normal levels for these liver enzymes, while the mean levels of
both AST and ALT for cases were above normal clinical ranges. AST and ALT tests were not done
for negative controls due to limited resources. Liver disease was excluded based on HBV and HCV
negative status and reports of no liver problems by these participants.
Table 1. Sociodemographic characteristics of study participants.
Variable Cases n = 38 Negative Controlsn = 136
Positive Controls
n = 102 p-Value
Sex – – – <0.0001
Male 29 (76.3%) 119 (88.1%) 66 (64.7%) –
Female 9 (23.7%) 16 (11.8%) 36 (35.3%) –
Age – – – 0.0370
Median 39 32 31 –
Mean and SD 37.4 + 11.4 32 + 8.7 33.1 + 11 –
ď24 4 (10.5%) 27 (20%) 25 (24.5%) –
25–34 11 (29%) 64 (47.4%) 36 (35.3%) –
35–44 15 (39.5%) 30 (22.2%) 23 (22.6%) –
ě45 8 (21.1%) 14 (10.4%) 18 (17.7%) –
Education – – – 0.1813
None 4 (16.7%) 5 (5.1%) 5 (6.7%) –
Primary 2 (8.3%) 4 (4.1%) 2 (2.7%) –
JSS/Secondary/Form/Technical 14 (58.3%) 68 (69.4%) 44 (58.7%) –
College/University 4 (16.7%) 21 (21.4%) 24 (32%) –
Ethnicity – – – 0.1223
Akan 28 (73.7%) 96 (71.1%) 84 (82.3%) –
Other 10 (26.3%) 40 (28.9%) 18 (17.7%) –
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Table 1. Cont.
Variable Cases n = 38 Negative Controlsn = 136
Positive Controls
n = 102 p-Value
Religion – – – 0.0937
Christian 32 (84.2%) 112 (82.9%) 94 (92.2%) –
Muslim/Other 6 (15.8%) 23 (17.1%) 8 (7.8%) –
Employment – – – 0.0625
Yes 31 (81.6%) 108 (80%) 69 (67.6%) –
No 7 (18.4%) 27 (20%) 33 (32.4%) –
Total household size – – – 0.8013
0–9 32 (84.2%) 109 (80.7%) 88 (86.3%) –
10–19 4 (10.5%) 20 (14.8%) 10 (9.8%) –
20 and above 2 (5.3%) 6 (4.4%) 4 (3.9%) –
JSS = Junior Secondary School. Other ethnic groups include Gruma, Busanga, Dagbani, Basare, Moshi, Hausa,
Ewe and Dagati.
Table 2. Aflatoxin M1, aspartate transaminase (AST) and alanine transaminase (ALT) levels for the
study groups.




n = 102 p-Value
AFM1 (pg/mg creatinine) – – – –
Mean ˘ SD 68.52 ˘ 679.8 67.02 ˘ 160.1 65.28 ˘ 334.1 0.9463
Median and Range 9.94; 0–679.88 7.72; 0–1173.09 6.76; 0–3019.69 –
AST (U/L) n = 16 Not done n = 11 –
Mean ˘ SD 184.74 ˘ 276.7 – 24.86 ˘ 5.2 0.0355
Median and Range 83.55; 18.7–1053.2 – 26; 15–32 –
ALT (U/L) n = 21 Not done n = 32 –
Mean ˘ SD 88 ˘ 53.7 – 27.25 ˘ 13.4 <0.0001
Median and Range 90; 11–199 – 22; 11–66 –
3.2. Food Preparation and Consumption Habits
There was statistically significant difference among the groups regarding who prepared the food
they ate. Approximately 43% of positive controls reported preparing their food themselves compared
to 32% of cases and 18.5% of negative controls. Approximately 48% of both cases and negative controls
reported that their wife or another female family member prepared their food compared to 31% of
positive controls (Table 3).
Table 3. Food preparation and consumption habits of participants.
Variable Cases n = 38 Negative Controlsn = 136
Positive Controls
n = 102 p-Values
Who prepares your food? – – – 0.0009
Self 12 (31.6%) 25 (18.5%) 44 (43.1%) –
Wife or other female family
member 18 (47.4%) 66 (48.9%) 32 (31.4%) –
Variation 8 (21%) 44 (32.6%) 26 (25.5%) –
Groundnut frequency – – – 0.4887
Never 21 (55%) 62 (45.6%) 53 (52%) –
1–3 times 17 (45%) 73 (53.7%) 49 (48%) –
Everyday 0 (0%) 1 (0.7%) 0 (0%) –
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Table 3. Cont.
Variable Cases n = 38 Negative Controlsn = 136
Positive Controls
n = 102 p-Values
Maize frequency (on the cob) – – – 0.2816
Never 11 (29%) 33 (24.3%) 28 (27%) –
1–3 times 27 (71%) 102 (75%) 69 (68%) –
Everyday 0 (0%) 1 (0.7%) 2 (2%) –
Groundnut paste or
butter frequency – – – 0.4927
1 time or less per week 34 (94.4%) 118 (90.8%) 90 (96.8%) –
2–3 times per week 2 (5.6%) 10 (7.7%) 3 (3.2%) –
Everyday 0 (0%) 2 (1.5%) 0 (0%) –
Groundnut soup and
sauce frequency – – – 0.4530
1 time or less per week 20 (60.6%) 64 (48.1%) 50 (53.8%) –
2–3 times per week 13 (39.4%) 63 (47.4%) 37 (39.8%) –
Everyday 0 (0%) 6 (4.5%) 6 (6.4%) –
Kenkey frequency – – – 0.4192
1 time or less per week 21 (58.3%) 59 (44.4%) 51 (52%) –
2–3 times per week 14 (38.9%) 63 (47.4%) 39 (39.8%) –
Everyday 1 (2.8%) 11 (8.3%) 8 (8.2%) –
Banku frequency – – – 0.1152
1 time or less per week 15 (42.9%) 42 (31.3%) 42 (43.7%) –
2–3 times per week 19 (54.3%) 75 (56%) 43 (44.8%) –
Everyday 1 (2.8%) 17 (12.7%) 11 (11.5%) –
Apeprensa/Asana frequency – – – 0.3399
1 time or less per week 38 (100%) 132 (98.5%) 96 (97%) –
2–3 times per week 0 (0%) 2 (1.5%) 3 (3%) –
Everyday 0 (0%) 0 (0%) 0 (0%) –
Numbers for variables may not always add up to the total number due to missing responses.
3.3. Aflatoxin Awareness and Knowledge of Study Participants
A slightly higher percent of cases than the other groups reported that they had heard of aflatoxin
previously, but the difference was not significant (Table 4). A higher percentage of cases than either
of the control groups also reported being aware of aflatoxin contamination of groundnuts and maize.
However, most cases (82%) reported that aflatoxin contamination cannot cause sickness in humans.
Awareness of aflatoxin contamination of crops and of the relationship of aflatoxin to disease was low
for all three groups.
Table 4. Aflatoxin awareness and knowledge among study participants.
Variable Cases n = 38 Negative Controlsn = 136
Positive Controls
n = 102 p-Value
Have you heard of aflatoxin before? 0.1479
Yes 22 (57.9%) 65 (48.5%) 41 (40.2%) –
No 16 (42.1%) 69 (51.5%) 61 (59.8%) –
Are you aware of aflatoxin contamination of groundnuts? 0.0547
Yes 19 (50%) 57 (42.5%) 31 (30.4%) –
No 19 (50%) 77 (57.5%) 71 (69.6%) –
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Table 4. Cont.
Variable Cases n = 38 Negative Controlsn = 136
Positive Controls
n = 102 p-Value
Are you aware of aflatoxin contamination of maize? 0.0506
Yes 22 (57.9%) 59 (44%) 36 (35.3%) –
No 16 (42.1%) 75 (56%) 66 (64.7%) –
Can aflatoxin cause sickness in humans? 0.0886
Yes 7 (18.4%) 39 (29.1%) 18 (17.6%) –
No 31 (81.6%) 95 (70.9%) 84 (82.4%) –
3.4. Sociodemographic Factors, Consumption Habits and Awareness of Aflatoxin as Predictors of Being a Case
Multivariable analysis showed that age was a significant predictor for being a case when cases
were compared to the negative controls (Table 5). The odds of being a case was 70% less for participants
aged 25–34 years (OR 0.30, 95% CI 0.10–0.88). Akans were seven times more likely to have AFM1 levels
below the median for cases when compared to other ethnic groups, which include Gruma, Busanga,
Dagbani, Basare, Moshi, Hausa, Ewe and Dagati (OR 7, CI 1.41–34.68). In the model in which cases
were compared to positive controls, cases were 2.29 times more likely to report awareness of aflatoxin
contamination of groundnuts (95% CI 1.06–4.91) and 2.5 times more likely to report awareness of
aflatoxin contamination of maize (95% CI 1.17–5.39). Cases were also two times more likely to report
awareness of aflatoxin contamination of maize than all controls combined (95% CI 17–5.39) (Table 5).
Table 5. Logistic Models of probability of being a case given food consumption habits and awareness
of aflatoxin.
Variable Case vs. All Controls * Cases vs. NegativeControls *
Case vs. Positive
Controls *
Age – – –
ď24 0.30 (0.08–1.10) 0.25 (0.06–1.01) 0.36 (0.09–1.38)
25–34 0.44 (0.16–1.18) 0.30 (0.10–0.88) 0.68 (0.23–2.01)
35–44 1.13 (0.43–2.96) 0.87 (0.30–2.54) 1.46 (0.51–4.22)
ě45 Referent Referent Referent
Who prepares your food – – –
Self Referent Referent Referent
Wife or other female family member 1.06 (0.48–2.33) 0.56 (0.24–1.34) 2.06 (0.87–4.87)
Variation 0.66 (0.25–1.71) 0.37 (0.13–1.05) 1.12 (0.40–3.12)
Maize consumption frequency – – –
Never Referent Referent Referent
1–3 times 0.43 (0.16–1.17) 0.47 (0.17–1.32) 0.39 (0.14–1.12)
Everyday 0.95 (0.20–4.52) 0.75 (0.15–3.76) 1.48 (0.23–9.33)
Banku consumption frequency – – –
1 time or less per week Referent Referent Referent
2–3 times per week 0.90 (0.43–1.87) 0.71 (0.32–1.54) 1.23 (0.55–2.75)
Everyday 0.20 (0.02–1.58) 0.16 (0.02–1.34) 0.25 (0.03–2.14)
Awareness of groundnut contamination – – –
Yes 1.69 (0.85–3.37) 1.36 (0.66–2.18) 2.29 (1.06–4.91)
No Referent Referent Referent
Awareness of maize contamination – – –
Yes 2.05 (1.02–4.11) 1.77 (0.85–3.66) 2.52 (1.17–5.39)
No Referent Referent Referent
Knowledge of causing disease in humans – – –
Yes 0.71 (0.29–1.71) 0.55 (0.22–1.36) 1.05 (0.40–2.76)
No Referent Referent Referent
* Models adjusted for gender, education, ethnicity, employment status and religion.
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4. Discussion
4.1. Sociodemographic and Clinical Characteristics of the Study Groups
It is interesting to note that a much higher percentage of participants in all groups were male.
It is known that men are twice as likely to develop liver cancer compared to women, and that in
developing countries the rate of liver cancer for men is 10 times that of women. It is believed that males
produce higher levels of interleukin-6 (IL-6), that promotes inflammation in response to liver injury,
than females, and that production of IL-6 is suppressed by estrogen [24]. IL-6 contributes to the chronic
liver inflammation that leads to cancer. This difference in males and females has been found to be due
to different upregulation or deregulation of genes associated with inflammatory pathways. Females
were found to be less vulnerable to “gender specific genes” than males [25]. When comparing the age
of the participants, cases had a statistically significant higher average age than either of the control
groups. This is not unexpected as it takes two or more decades for development of hepatocellular
carcinoma [26].
Our finding of no significant difference in mean AFM1 levels among cases, positive controls and
negative controls may be a result of the constant daily exposure of all three groups to aflatoxin in
the diet. The higher median AFM1 levels among cases may be the result of greater aflatoxin intake
or as a result of liver damage. The AFM1 metabolite is excreted in urine in 24–48 h after aflatoxin
ingestion [27]. Although we realize that a single AFM1 measurement is not the ideal way to examine
the association between aflatoxin exposure and liver disease, we were unable to do multiple AFM1
measurements or to determine the AFB1 biomarker, which indicates more long-term aflatoxin exposure
(2–3 months or more). However, because of the chronic dietary exposure of people in this region of
Ghana to aflatoxin, urinary excretion of AFM1 can almost always be detected reliably. In a previous
study that we conducted in Ghana, we found AFM1 in at least 91% of study participants [28]. We also
found AF-ALB in 100% of these participants indicating concurrent presence of both biomarkers [28].
As expected, mean levels of liver enzymes, AST and ALT, were significantly different between
cases and positive controls. Mean levels of AST and ALT were above normal clinical ranges for cases
but remained within normal levels for positive controls.
Akans were seven times more likely to have AFM1 levels below the median aflatoxin level for
cases when compared to those in other ethnic groups (OR 7, CI 1.41–34.68). The diet of Akans seems to
be more varied in that they eat other products, such as, yams, rice and plantains compared to ethnic
groups in the society (the Gruma, Busanga, Dagbani, Basare, Moshi, Hausa, Ewe and Dagati) who may
eat mainly groundnut, maize and other cereal-based diets. We found previously in a study conducted
in Ghana that ethnicity tended to be a predictor of high AFB1 levels. Participants belonging to the
Dagbani, Basare/Basali, Gonja and Konkomba ethnic group tended to be 2.8 times as likely to have
high AFB1 levels compared to those from the Akan group [28].
Awareness of aflatoxin contamination of crops and of the relationship of aflatoxin to disease was
low among all three groups. However, in the model in which cases were compared to positive controls,
cases were 2.29 times more likely to report awareness of aflatoxin contamination of groundnuts
(95% CI 1.06–4.91), and 2.52 times more likely to report aflatoxin contamination of maize (95% CI
17–5.39) (Table 5). Regrettably, most of these cases reported that aflatoxin contamination does not
cause sickness in humans. This shows that awareness of aflatoxin contamination may occur without
proper understanding of the serious potential adverse health impacts of the toxin. Another study
conducted in Ghana reported the difficulty in guaranteeing the receptiveness of public awareness
campaigns should they contradict beliefs, particularly because maize-based foods are staple to the
average Ghanaian diet [29]. As a result there is continued consumption of aflatoxin-contaminated
foods despite aflatoxin awareness.
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4.2. Food Preparation and Consumption Habits
A statistically significant higher percent (43%) of positive controls reported preparing their own
food compared with cases (32%) and negative controls (18.5%). Approximately 48% of both cases
and negative controls reported that their wife or another female family member prepared their food
compared to 31% of positive controls. Spouses and female family members may not be careful to
select wholesome grains, to store grains properly, and to sort out contaminated grains before cooking.
This could have placed cases at high risk for aflatoxin exposure over time. Negative controls are at this
same risk but are younger and so do not yet show the effect of chronic aflatoxin exposure. A study
conducted in Ghana to assess the relationship between food preparation, contamination awareness,
and food safety found that although individuals responsible for preparing food, as well as consumers,
were aware of possible food contamination, this knowledge was not reflective in their preparation or
consumption practices [29]. A factor that should be considered when questioning the effectiveness of
aflatoxin contamination awareness is the economic status of study participants since many participants
expressed that their food preparation and consumption practices were heavily influenced by whether
or not they could afford to discard seemingly unsafe foods. This was true for consumers as well as
farmers and vendors.
4.3. Limitations
There are several limitations of this study that should be considered in interpreting the results.
The first is the small number of cases that we were able to recruit which likely precluded us from
obtaining some significant results. The age difference between cases and controls is a limitation that
was difficult to overcome, partly because cancer develops after two or more decades, but also because
we had to recruit controls from the Transfusion Medicine Unit of the hospital in order to know their
HBV and HCV infection status. An additional limitation is the use of a single AFM1 measurement to
examine the association between aflatoxin exposure and liver disease, but limited resources prevented
us from conducting multiple AFM1 measurements.
5. Conclusions, Potential Interventions and Future Research
Despite the limitations, this study identifies factors that contribute to aflatoxin ingestion in this
population, and points to interventions that, if implemented, may reduce aflatoxin exposure and
possibly decrease liver disease and liver cancer in the population. The finding of high AFM1 levels in
urine of all groups of study participants confirms chronic dietary exposure to aflatoxin. The significant
finding of higher levels of awareness of aflatoxin contamination in maize and groundnuts among
the cases without proper understanding of the serious potential adverse health impact of aflatoxin
exposure, indicates the need for educational programs that address awareness of the harmful health
effects of aflatoxin, emphasize that these harmful effects occur as a result of years of chronic exposure to
the toxin, and stress that current attention to the problem is crucial. The preponderance of males in the
study sample highlights the higher liver cancer risk for males and indicates that this increased risk for
males should be emphasized in educational awareness and intervention programs. The significantly
lower median AFM1 levels observed among Akans compared to the other ethnic groups in the study
may indicate that the more varied diet observed in Akans [28] could result in less aflatoxin exposure.
If further investigation into the diets of the different groups show that some groups eat mainly foods
that are more prone to aflatoxin contamination, then the information could be used in developing
interventions to assist groups in the society to vary their diets using available and inexpensive local
food crops. This may prove to be effective in decreasing aflatoxin exposure. Interventions that
incorporate simple pre- and post-harvest strategies to decrease fungal proliferation, and build-up
of aflatoxin, in foods, and address simple food selection, storage, preparation, and consumption
approaches to decrease aflatoxin exposure are also urgently needed. Further research concerning
the effects of aflatoxin exposure levels in HBV and HCV positive and negative people are needed to
Int. J. Environ. Res. Public Health 2016, 13, 377 10 of 11
advocate for effective regulatory policies to reduce aflatoxin contamination in food. These regulations
may potentially decrease aflatoxin exposure levels in Ghana and other countries where staple crops
are highly prone to aflatoxin contamination.
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